These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 24298907

  • 21. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis.
    Ku JH, Henkle E, Carlson KF, Marino M, Brode SK, Marras TK, Winthrop KL.
    Chest; 2024 May; 165(5):1058-1069. PubMed ID: 38086472
    [Abstract] [Full Text] [Related]

  • 22. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ.
    Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330
    [Abstract] [Full Text] [Related]

  • 23. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL, Fisher EJ, Peng GT, Hodges JS, Chesnut J, Child CC, Franchino B, Gibert CL, El-Sadr W, Hafner R, Korvick J, Ropka M, Heifets L, Clotfelter J, Munroe D, Horsburgh CR.
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Roxithromycin therapy of patients with mycobacterium avium complex lung infection].
    Matsuda H, Sennda K, Suda T, Kuwata H, Suzuki K, Yokomura K, Asada K, Nakamura Y, Inui N, Tsuchiya T, Nakamura H.
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():13-5. PubMed ID: 11436830
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM, Sullam PM, Shafran SD, Cohn DL, Wynne B, Paxton L, Perry K, Horsburgh CR.
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [Abstract] [Full Text] [Related]

  • 29. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT, Rimland D, Kauffman C, Huycke M, Evans TG, Heifets L.
    Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
    [Abstract] [Full Text] [Related]

  • 30. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
    Chaisson RE, Keiser P, Pierce M, Fessel WJ, Ruskin J, Lahart C, Benson CA, Meek K, Siepman N, Craft JC.
    AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
    [Abstract] [Full Text] [Related]

  • 31. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
    Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP.
    Thorax; 2008 Jul; 63(7):627-34. PubMed ID: 18250184
    [Abstract] [Full Text] [Related]

  • 32. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease.
    Kobashi Y, Matsushima T, Oka M.
    Respir Med; 2007 Jan; 101(1):130-8. PubMed ID: 16750618
    [Abstract] [Full Text] [Related]

  • 33. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T, Matsui H, Hirose T, Suzuki J, Saito M, Akaba T, Kobayashi K, Akashi S, Kawashima M, Tamura A, Nagai H, Akagawa S, Kobayashi N, Ohta K.
    BMC Infect Dis; 2016 Jan 27; 16():31. PubMed ID: 26818764
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ, Jeong BH, Jeon K, Lee SY, Shin SJ.
    Am J Respir Crit Care Med; 2012 Oct 15; 186(8):797-802. PubMed ID: 22878282
    [Abstract] [Full Text] [Related]

  • 35. [A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease].
    Ichiki H, Watanabe A, Ueda S, Sato C, Abe M.
    Kekkaku; 2012 Jul 15; 87(7):487-90. PubMed ID: 22993889
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease.
    Griffith DE, Brown BA, Girard WM, Griffith BE, Couch LA, Wallace RJ.
    Clin Infect Dis; 2001 Jun 01; 32(11):1547-53. PubMed ID: 11340525
    [Abstract] [Full Text] [Related]

  • 38. [The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection].
    Yamamoto M, Kuze F, Sakatani M, Saito H, Shimoide H, Soejima R, Hara K.
    Kekkaku; 1997 Jan 01; 72(1):1-7. PubMed ID: 9038009
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.